The survival curves of the two groups of patients with primary VSCC tumours classified by the percentage of CD66b + neutrophils are shown in Fig. 2D. Median disease-free survival rates were 101 and 5 months in patients with low and higher percentages of CD66b + neutrophils, respectively. The gene discussed is CEACAM8; the disease is neoplasm.